Illumina, Inc.

Illumina, Inc. is a genomics company founded in 1998 and headquartered in San Diego, California. It develops and provides sequencing and array technologies and integrated systems for the analysis of genetic variation and function. The company operates globally and is described in its own materials as a leader in the genomics market.

Its product portfolio spans instruments, consumables and software. Hardware and reagent offerings include the NovaSeq X high-throughput sequencing platform, NextSeq systems, microarray scanners and library preparation kits. On the informatics side, BaseSpace Sequence Hub provides a cloud-based solution for sequencing data, while DRAGEN supports genomic analysis. The associated technical domains cover DNA sequencing, genomics, microarray technology, bioinformatics, genetic variation analysis, precision health and sequencing informatics.

Illumina's technologies are applied across cancer research, reproductive health, genetic disease research, translational genomics, consumer genomics, clinical diagnostics and life science research. Its stated mission is to improve human health by unlocking the power of the genome, with an emphasis on making genomics more accessible to researchers, clinicians and patients and on enabling breakthroughs that protect future generations.